Yahoo! Canada Finance: Biotechnology Industry News

Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2009 Siemens Competition Regional Winners An

Sun, 08 Nov 2009 02:47:00 GMT

PRNewswire - Research projects in the areas of mathematics and biochemistry scored top marks this evening, as Tim Kunisky of Livingston, NJ and the team of Benjamin Song and Quan (Jack) Chen of Audubon, PA received the highest honors at the Region Five Finals of the 2009 Siemens Competition in Math, Science & Technology, the nation's premier high school science competition.

DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations

Sat, 07 Nov 2009 12:00:27 GMT

Business Wire - An analysis demonstrating the ability of DX-88 (ecallantide) to resolve symptoms of acute hereditary angioedema (HAE) attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology (ACAAI) 2009 Annual Meeting in Miami Beach.

Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme

Sat, 07 Nov 2009 02:00:27 GMT

Business Wire - Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010

Sat, 07 Nov 2009 01:15:22 GMT

Business Wire - GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S.

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

Sat, 07 Nov 2009 00:10:37 GMT

PRNewswire - SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.

CardioNet, Inc. Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 22:14:38 GMT

Business Wire - CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter and nine months ended September 30, 2009.

Floridas Agency for Health Care Administration Previews Online Personal Health Records for Medicaid Recipients

Fri, 06 Nov 2009 21:19:31 GMT

Business Wire - Florida’s Agency for Health Care Administration (Agency) has previewed the first phase of Florida’s free, Internet-based personal health record, My Florida Health eBook and My Florida eBaby Book.

Covidien Completes Acquisition of Aspect Medical Systems Inc.

Fri, 06 Nov 2009 21:18:57 GMT

Business Wire - Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Aspect Medical Systems Inc. for an aggregate consideration of approximately $210 million, net of cash and short-term investments acquired.

Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009

Fri, 06 Nov 2009 21:05:05 GMT

PRNewswire - Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a previously approved reverse split of its common stock will take effect at the start of trading on Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted basis.

PPD to Present at CHINATRIALS 2009

Fri, 06 Nov 2009 21:00:34 GMT

Business Wire - PPD, Inc. (Nasdaq:PPDI) today announced Simon Britton, vice president of clinical development, Asia Pacific, will present at the CHINATRIALS 2009 Global Clinical Development Summit in Beijing on November 8-10.

Microbix Biosystems Re-files Annual Results With OSC

Fri, 06 Nov 2009 21:00:25 GMT

CNW Group - Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended September 30, 2008.

Watson to Present at Credit Suisse Healthcare Conference

Fri, 06 Nov 2009 21:00:19 GMT

PRNewswire - Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern Standard Time.

Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering

Fri, 06 Nov 2009 20:43:33 GMT

PRNewswire - Trius Therapeutics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S.

2009 Mid-Atlantic Bio Conference Attracts Record Number of Bioscience Companies

Fri, 06 Nov 2009 20:24:31 GMT

Business Wire - The 2009 Mid-Atlantic Bio Conference drew more than 750 participants—including a record number of more than 300 bioscience companies in attendance—for its annual bioscience and investor conference.

Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th

Fri, 06 Nov 2009 20:10:21 GMT

CNW Group - Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City.

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2010 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST

Fri, 06 Nov 2009 20:06:16 GMT

GlobeNewswire - Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, November 10, 2009 at 4:30 P.M.

AIPL Announces Premier Opthalmic Pathology Consultation Group

Fri, 06 Nov 2009 20:04:28 GMT

Business Wire - American International Pathology Laboratories™ (AIPL™) announces the formation of the first ever multi-subspecialty group to diagnose Opthalmic Pathology cases.

Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009

Fri, 06 Nov 2009 19:45:54 GMT

Business Wire - Celsion Corporation (NASDAQ:CLSN), a late stage clinical oncology development company that is leveraging its heat activated liposomal technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that it will hold a conference call to discuss third quarter 2009 results at 11:00 a.m.

Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council

Fri, 06 Nov 2009 18:00:30 GMT

Business Wire - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the Mass Technology Leadership Council, Inc. named Phase Forward Private Sector Company of the Year at the 2009 Mass Technology Leadership Awards in Boston last night.

Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 18:00:13 GMT

PRNewswire - BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009.

Novak Druce + Quigg LLP Speaks on Patent Reform at BioFlorida Annual Conference

Fri, 06 Nov 2009 17:26:23 GMT

Business Wire - This morning, Novak Druce + Quigg LLP Executive Partner Tracy W. Druce spoke on patent reform...

Washington Biotechnology & Biomedical Associations New Healthcare Economics in WA Breaking News is Powered by MedIntelliBase® Intelligence Services

Fri, 06 Nov 2009 16:10:24 GMT

Business Wire - Visitors to the newly branded and redesigned website of the Washington Biotechnology & Biomedical Association (WBBA) to be featured at the WBBA’s Annual Meeting today will get free, timely, Washington state-focused biotech and medtech news through its “Economic Issues in WA Healthcare” Breaking News feature.

Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renew

Fri, 06 Nov 2009 15:15:54 GMT

PRNewswire - Myriant Technologies LLC ("Myriant"), a privately-held, biotech developer and manufacturer of renewable bio-chemicals, Uhde Corporation of America and its preferred technology provider Uhde GmbH, one of the world's leading engineering contractors (jointly "Uhde"), announced an alliance for the engineering, procurement & construction (EPC) of Myriant's biobased Succinic Acid plants based on renewable feedstocks.

Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris

Fri, 06 Nov 2009 15:07:12 GMT

Business Wire - Locus Pharmaceuticals, a drug company that has developed its own internal and partnered pipeline, focusing on oncology, immunology, and inflammatory targets, today announced that in conjunction with a transformation to a drug discovery collaboration business model, it has created a new division, Ansaris, which will include most of its operations and personnel.

Medtronic Receives Presidents E Award in Recognition of Its Support of U.S. Exports

Fri, 06 Nov 2009 15:00:37 GMT

Business Wire - Recognizing its significant contributions to increasing U.S. exports, Medtronic, Inc., (NYSE: MDT) received President Barack Obama’s “E” Award on Thursday, Nov. 5.

PPD Completes Acquisition of Excel PharmaStudies

Fri, 06 Nov 2009 14:28:33 GMT

Business Wire - PPD, Inc. (Nasdaq: PPDI) today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China.

Medicago announces $10,080,000 bought deal equity financing

Fri, 06 Nov 2009 14:07:33 GMT

CNW Group - Medicago Inc. ("Medicago") (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into an agreement to sell, on a bought deal basis (the "Offering"), 14,000,000 subscription receipts (the "Subscription Receipts") at a price of C$0.72 per Subscription Receipt to a syndicate of underwriters led by Paradigm Capital Inc., for gross proceeds to the Company of C$10,080,000 million.

Helix BioMedix Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 14:07:09 GMT

Business Wire - Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2009.

RiskMetrics Group Recommends Stockholders Vote FOR Life Sciences Research/Lion Holdings Merger

Fri, 06 Nov 2009 14:02:58 GMT

Business Wire - Life Sciences Research, Inc. (NYSE Arca: LSR) announced today that RiskMetrics Group (formerly Institutional Shareholder Services), a leading proxy advisory firm, has recommended that LSR stockholders vote “FOR” the approval of the merger of LSR and Lion Merger Corp. pursuant to the Agreement and Plan of Merger, dated as of July 8, 2009, among LSR, Lion Merger Corp. and Lion Holdings, Inc. at the upcoming special meeting of stockholders scheduled to be held on November 23, 2009.

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting

Fri, 06 Nov 2009 14:00:36 GMT

PRNewswire - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting held in Miami Beach, Florida, from November 5th to 7th.

LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference

Fri, 06 Nov 2009 14:00:22 GMT

Business Wire - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 18th Annual Healthcare Conference in Phoenix AZ.

GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update

Fri, 06 Nov 2009 14:00:17 GMT

PRNewswire - GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ("GeoVax" or "the Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus

Fri, 06 Nov 2009 13:35:14 GMT

PRNewswire - Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S.

Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)

Fri, 06 Nov 2009 13:35:04 GMT

Business Wire - Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company’s clinical program to treat Adrenoleukodystrophy (ALD).

Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant Company updates third quarter financial results and full-y

Fri, 06 Nov 2009 13:30:28 GMT

PRNewswire - Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005.

Global Biotech Corp. Announces Listing on CNSX

Fri, 06 Nov 2009 13:30:12 GMT

Marketwire - Global Biotech Corp. (CNSX:GBQ) (the "Company") is pleased to announce that it has satisfied the listing requirements of the Canadian National Stock Exchange (the "CNSX"), and the Company's common shares will be listed on the CNSX for public trading beginning on Friday, November 6, 2009.

QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader) at MEDICA 2009, the Worlds Leading Medical Trade Fair

Fri, 06 Nov 2009 13:22:29 GMT

Business Wire - QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that the Company will demonstrate its latest technology at MEDICA 2009, the world's leading medical trade fair, to be held November 18-21, 2009, in Düsseldorf, Germany.

Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference

Fri, 06 Nov 2009 13:15:55 GMT

Business Wire - Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that its presentation at the 2009 Annual Credit Suisse Health Care Conference will be webcast and may be accessed at www.sucampo.com.

GTC Biotherapeutics Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 13:02:01 GMT

Business Wire - GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008.

Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results

Fri, 06 Nov 2009 13:00:25 GMT

PRNewswire - Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), today reported recent accomplishments and financial results for the third quarter and nine months ended September 30, 2009.

TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post

Fri, 06 Nov 2009 12:32:17 GMT

Business Wire - TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the appointment of Julie Lekstrom Himes, M.D. to join TARIS in the position of Chief Medical Officer and Senior Vice President for Clinical Development.

NeurogesX Reports Third Quarter 2009 Results Conference Call Today at 9am ET

Fri, 06 Nov 2009 12:30:21 GMT

PRNewswire -

Halozyme Therapeutics Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 12:29:52 GMT

Business Wire - Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

RXi Pharmaceuticals Appoints Noah D. Beerman as CEO

Fri, 06 Nov 2009 12:15:24 GMT

Business Wire - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Noah D.

ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society

Fri, 06 Nov 2009 12:13:33 GMT

Business Wire - ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.

Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.

Fri, 06 Nov 2009 12:07:42 GMT

Business Wire - Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares of common stock of Aspect Medical Systems, Inc.

Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call

Fri, 06 Nov 2009 12:05:57 GMT

Business Wire - Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced the date and time for its third quarter 2009 corporate update and pipeline review conference call.

Inhibitex Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 12:02:10 GMT

Business Wire - Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the third quarter ended September 30, 2009.

The Quigley Corporation to Announce Third Quarter Results and Host Audio Web Cast

Fri, 06 Nov 2009 12:00:59 GMT

PRNewswire - The Quigley Corporation, (Nasdaq: QGLY), www .quigleyco.com, today announced it will issue its third quarter results at 8:30 AM (ET) on Thursday, November 12, 2009.

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009

Fri, 06 Nov 2009 12:00:48 GMT

PRNewswire - Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today reported results for the third quarter and nine-months ended September 30, 2009.

LAB Research to hold third quarter 2009 financial results conference call and webcast

Fri, 06 Nov 2009 11:30:21 GMT

CNW Group - LAB Research Inc. ("LAB" or "LAB Research") (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it will report financial results for the third quarter of 2009 on Thursday, November 12, 2009.

Amarin Appoints John F. Thero as Chief Financial Officer

Fri, 06 Nov 2009 09:15:28 GMT

Business Wire - Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of John F. Thero as...

Artimplant Interim Report January September 2009

Fri, 06 Nov 2009 07:56:26 GMT

Business Wire - Regulatory News:

Quintiles Opens Expanded Asia-Pacific Headquarters in Singapore

Fri, 06 Nov 2009 02:30:30 GMT

Business Wire - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore’s Science Park I.

Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services Appoints Dr. James Matsuura As Director, Formulation

Fri, 06 Nov 2009 02:20:59 GMT

PRNewswire - Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr.